Lead sponsor
vTv Therapeutics
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
0
Ongoing
1,228
Total enrollment
156
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
1
Phase 3
2
Trials by status
Completed
1
Terminated
3
Trials led
TrialEligibility highlightPhaseStatusEnrollment
2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)Study partner/caregiver requiredPh 3Terminated297